Long-term treatment of chronic hepatitis B

Long-term treatment of chronic hepatitis B

Nucleos(t)ide analogs (NAs) have been successfully used for treatment of chronic hepatitis B. Hepatitis B virus (HBV) replication is now recognized as the key driver of liver injury and disease progression, so the primary aim of treatment for chronic HBV infection is to maximize sustained suppressio...

Full description

Bibliographic Details
Main Author:	Experts attending the discussion on long-treatment of chronic hepatitis B
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Hepatology 2014-11-01
Series:	Linchuang Gandanbing Zazhi
Subjects:	hepatitis B chronic; nucleoside and nucleotide analogs; long-term treatment; management; guidebooks
Online Access:	http://www.lcgdbzz.org/qk_content.asp?id=6106&ClassID=101792734

Similar Items

Drug resistance to nucleoside and nucleotide analogs in chronic hepatitis B and its management
by: Experts Attending the Disscussion on Hepatitis B Virus Drug Resistance
Published: (2013-01-01)

Expert consenus on antiviral therapy for special patients with chronic hepatitis B: an update in 2014
by: Committee of experts on antiviral therapy for special patients with chronic hepatitis B
Published: (2014-07-01)

Expert consensus on clinical management of adverse reactions in interferon-α therapy for chronic viral hepatitis
by: Expert Committee on Clinical Management of Adverse Reactions in Interferon-α Therapy for Chronic Viral Hepatitis
Published: (2014-11-01)

Antiviral efficacy of entecavir for hepatitis B virus rtA181V/T mutants
by: Ping Li, et al.
Published: (2017-04-01)

Meta-analysis of the clinical efficacy of combination therapy with traditional Chinese medicine and nucleoside analogue antiviral drugs for chronic hepatitis B
by: REN Shuang
Published: (2013-04-01)

Change in HBsAg quantification after HBV DNA negative conversion in chronic hepatitis B patients treated with nucleos(t)ide analogues
by: ZHOU Youqian, et al.
Published: (2019-05-01)

Effects of nucleos(t)ide analogues on estimated glomerular filtration rate and serum creatinine level in patients with chronic hepatitis B
by: XU Yong, et al.
Published: (2016-02-01)

Research advances in drug resistance to nucleos(t)ide analogues in treatment of chronic hepatitis B
by: FAN Xiu
Published: (2015-04-01)

Clinical significance of serum HBV RNA measurement in chronic hepatitis B patients
by: LU Fengmin, et al.
Published: (2018-05-01)

Poor adherence is a contributor to viral breakthrough in patients with chronic hepatitis B
by: Wang L, et al.
Published: (2018-11-01)

The course and treatment of chronic hepatitis B in HIV-infected patients
by: Semen Leonidovich Maksimov, et al.
Published: (2010-11-01)

Adherence to Nucleoside/Nucleotide Analogue Treatment in Patients with Chronic Hepatitis B
by: Emin Ediz Tütüncü, et al.
Published: (2017-12-01)

Is HBV viral load at admission associated with development of acute-on-chronic liver failure in patients with acute decompensation of chronic hepatitis B related cirrhosis?
by: Jian-Hua Lei, et al.
Published: (2019-04-01)

Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections
by: Erik De Clercq, et al.
Published: (2010-05-01)

Clinical characteristics of chronic hepatitis B cured by peginterferon in combination with nucleotide analogs
by: Xuli Bao, et al.
Published: (2020-07-01)

Addition of nucleoside analogues to peg-IFNα-2a enhances virological response in chronic hepatitis B patients without early response to peg-IFNα-2a: a randomized controlled trial
by: Yan Xu, et al.
Published: (2017-08-01)

Expert interpretation of the “KASL Clinical Practice Guidelines: Management of hepatitis C”
by: DING Yang
Published: (2015-01-01)

A Dynamic Model for Predicting Outcome in Patients with HBV Related Acute-On-Chronic Liver Failure
by: Wei Lin, et al.
Published: (2018-05-01)

Long-Term Results of the Etiotropic Therapy of Subcompensed Liver Cirrhosis in the Outcome of Chronic Hepatitis C
by: P. O. Bogomolov, et al.
Published: (2020-01-01)

SELECTING THE MANAGEMENT OF PATIENTS WITH CHRONIC HEPATITIS B AFTER THE COMPLETION OF THE LONG-TERM ANTIVIRAL THERAPY
by: E. V. Esaulenko, et al.
Published: (2018-10-01)

Key points of the AASLD’s guidelines on hepatitis C diagnosis and treatment
by: YANG Ming
Published: (2013-02-01)

Several opinions on EASL recommendations on treatment of hepatitis C (April 2014)
by: DAI Mingjia
Published: (2014-08-01)

核苷和核苷酸类药物抗HBV应用分析
by: YANG Weimin
Published: (2014-05-01)

CHRONIC HEPATITIS B VIRUS INFECTION IN PREGNANCY: STRATEGIES OF ANTIVIRAL THERAPY
by: P. O. Bogomolov, et al.
Published: (2016-02-01)

Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade
by: Hyung Joon Yim, et al.
Published: (2013-09-01)

Development of MTH1-Binding Nucleotide Analogs Based on 7,8-Dihalogenated 7-Deaza-dG Derivatives
by: Hui Shi, et al.
Published: (2021-01-01)

Combination therapy and sequential therapy with interferons and nucleos(t)ide analogues against HBV
by: LI Qiang
Published: (2015-04-01)

New strategies for clinical cure and Institute of hepatitis B: viral suppression combined with immune modulation and its road map
by: WU Di, et al.
Published: (2018-05-01)

Recommendation on antiviral therapy to hepatitis B/C virus related hepatocellular carcinoma
by: Liver Cancer Study Group，Chinese Society of Hepatology，Chinese Medical Association
Published: (2013-01-01)

Research progress in dynamic evolution characteristics of nucleos(t)ide analogue-resistant mutants
by: WANG Yang
Published: (2015-04-01)

Explanation of the “Recommendation on antiviral therapy to hepatitis B/C virus related hepatocellular carcinoma”
by: DONG Jing
Published: (2013-01-01)

Explanation of the “Expert consensus on antiviral therapy to hepatitis B/C virus-related hepatocellular carcinoma”
by: DONG Jing
Published: (2014-07-01)

Long-Term Follow-up and Quantitative Hepatitis B Surface Antigen Monitoring in North American Chronic HBV Carriers
by: Conar R. O’Neil, et al.
Published: (2018-03-01)

Management of Hepatitis B Virus Infection in Liver Transplant Recipients
by: Joy Varghese, et al.
Published: (2013-12-01)

Therapeutic efficacy of combination therapy with interferon and a nucleoside analogue for treating chronic hepatitis B patients
by: HE Yan
Published: (2013-02-01)

Host genetic factors in predicting response status in chronic hepatitis B patients discontinuing nucleos(t)ide analogs
by: Tao Li, et al.
Published: (2018-01-01)

Clinical features of patients developing primary hepatocellular carcinoma during anti-HBV therapy with nucleos(t)ide analogues
by: ZHANG Ying, et al.
Published: (2017-04-01)

Towards the elimination and eradication of hepatitis B
by: Geoffrey Dusheiko
Published: (2015-01-01)

Outcomes of nucleoside analogue-based salvage therapy in patients with multidrug-resistant chronic hepatitis B
by: SONG Minning
Published: (2013-08-01)

Corrigendum: Modular Enzymatic Cascade Synthesis of Nucleotides Using a (d)ATP Regeneration System
by: Maryke Fehlau, et al.
Published: (2020-10-01)